Jul 04, 2014
From the Healthcare & Life Sciences Institute
This report, titled Growing the pipeline, growing the bottom line: Shifts in pharmaceutical R&D innovation, looks at the great research challenge through the eyes of senior R&D executives from some of the world’s leading pharma companies.
Their responses suggest:
- Pharmaceutical R&D innovation is on the rise, with 70 percent of respondents believing their companies are enjoying a resurgence in research productivity
- Organizational barriers to R&D innovation persist: 72 percent of respondents claim that excessive administrative work prevents scientists from devoting time to research
- Pharmaceutical R&D outsourcing and collaboration is set to continue, with an increasing proportion of research budgets spent externally